Pilloxa is one of the 10 companies in Scandinavia that was awarded the EIT Health Headstart funding of € 50 000. EIT Health is the life science division of EIT which is an EU organization that spurs innovation and entrepreneurship across Europe to overcome some of its greatest challenges. The funds will be used to further verify Pilloxa in a clinical context together with transplanted patients. For additional info about the news and about EIT Health, click here EIT Health
Pilloxa Receives Funding from the European EIT Health!
